Guardant Health Inc (NAS:GH)
$ 22.3 -0.26 (-1.15%) Market Cap: 2.74 Bil Enterprise Value: 3.08 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 72/100

Guardant Health Inc ECLIPSE Study Update Call Transcript

May 09, 2023 / 03:00PM GMT
Release Date Price: $23.99 (+1.95%)
Operator

Good morning, ladies and gentlemen, and welcome to the Guardant Health ECLIPSE Study Update Call. (Operator Instructions) This call is being recorded on Tuesday, May 9, 2023.

I would now like to turn the conference over to Dr. Craig Eagle, Chief Medical Officer of Guardant Health. Please go ahead.

Craig Eagle
Guardant Health, Inc. - Chief Medical Officer

Right. Thank you very much, and welcome, everybody. Joining me today are Dr. Chung, Gastroenterologist at Massachusetts General Hospital, Professor of Medicine at Harvard Medical School, and investigator on the ECLIPSE study, and the presenting author of the data this morning. Welcome, Dr. Chung. I also have Dr. Grady, Gastroenterologist and Medical Director of the Gastrointestinal Cancer Prevention Program and Professor in the Clinical Research Division and Professor in the Public Health Sciences Division at Fred Hutch, and Professor in the Division of Gastroenterology at the University of Washington, and senior investigator for the ECLIPSE study. Welcome, Dr. Grady.

Also joining us is Dr.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot